UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| For the quarterly period ended March 30, 2003 or | ||
| o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number
000-12933
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 94-2634797 | |
|
|
||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES x NO o
As of May 2, 2003, there were 126,819,270 shares of Registrants Common
Stock outstanding.
LAM RESEARCH CORPORATION
TABLE OF CONTENTS
| Page No. | |||||
PART I. Financial Information |
|||||
Item 1. Financial Statements (unaudited): |
3 | ||||
Condensed Consolidated Balance Sheets as of March 30, 2003 and June 30, 2002 |
3 | ||||
Condensed Consolidated Statements of Operations for the three and nine months ended March 30, 2003 and March 31, 2002 |
4 | ||||
Condensed Consolidated Statements of Cash Flows for the nine months ended March 30, 2003 and March 31, 2002 |
5 | ||||
Notes to Condensed Consolidated Financial Statements |
6 | ||||
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations |
24 | ||||
Item 3. Quantitative and Qualitative Disclosures about Market Risk |
51 | ||||
Item 4. Controls and Procedures |
51 | ||||
PART II. Other Information |
51 | ||||
Item 1. Legal Proceedings |
51 | ||||
Item 6. Exhibits and Reports on Form 8-K |
52 | ||||
Signatures |
53 | ||||
Certifications |
54 | ||||
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
| March 30, | June 30, | ||||||||
| 2003 | 2002 | ||||||||
| (unaudited) | (1) | ||||||||
Assets |
|||||||||
Cash and cash equivalents |
$ | 96,406 | $ | 172,431 | |||||
Short-term investments |
369,460 | 701,774 | |||||||
Accounts receivable, net |
133,110 | 132,113 | |||||||
Inventories |
126,690 | 180,799 | |||||||
Deferred income taxes |
128,577 | 125,227 | |||||||
Other current assets |
17,750 | 43,080 | |||||||
Total current assets |
871,993 | 1,355,424 | |||||||
Property and equipment, net |
53,242 | 67,496 | |||||||
Restricted cash |
119,438 | 70,983 | |||||||
Deferred income taxes |
88,307 | 86,231 | |||||||
Other assets |
62,880 | 52,157 | |||||||
Total assets |
$ | 1,195,860 | $ | 1,632,291 | |||||
Liabilities and stockholders equity |
|||||||||
Trade accounts payable |
$ | 30,622 | $ | 59,806 | |||||
Accrued expenses and other
current liabilities |
161,430 | 159,012 | |||||||
Deferred profit |
47,315 | 63,435 | |||||||
Current portion of long-term debt and other
long-term liabilities |
5,160 | 315,291 | |||||||
Total current liabilities |
244,527 | 597,544 | |||||||
Long-term debt and other long-term liabilities
less current portion |
321,718 | 359,691 | |||||||
Total liabilities |
566,245 | 957,235 | |||||||
Commitments and contingencies |
|||||||||
Preferred stock, at par value of $0.001 per share;
authorized 5,000 shares, none outstanding |
| | |||||||
Common stock, at par value of $0.001 per share;
authorized 400,000 shares; issued and
outstanding 126,150 shares at March 30,
2003 and 127,978 shares at June 30, 2002 |
126 | 128 | |||||||
Additional paid-in capital |
551,752 | 542,228 | |||||||
Deferred compensation |
(2,979 | ) | | ||||||
Treasury stock, at cost |
(44,508 | ) | (9,100 | ) | |||||
Accumulated other comprehensive loss |
(16,681 | ) | (15,240 | ) | |||||
Retained earnings |
141,905 | 157,040 | |||||||
Total stockholders equity |
629,615 | 675,056 | |||||||
Total liabilities and stockholders equity |
$ | 1,195,860 | $ | 1,632,291 | |||||
(1) Derived from June 30, 2002 audited financial statements.
See Notes to Condensed Consolidated Financial Statements.
3
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| March 30, | March 31, | March 30, | March 31, | ||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
Total revenue |
$ | 187,059 | $ | 164,105 | $ | 569,148 | $ | 762,858 | |||||||||
Cost of goods sold |
111,838 | 109,118 | 342,744 | 516,732 | |||||||||||||
Cost of goods sold restructuring
charges (recoveries) |
| | (301 | ) | 7,600 | ||||||||||||
Cost of goods sold patent
settlement |
| | | 38,780 | |||||||||||||
Total cost of goods sold |
111,838 | 109,118 | 342,443 | 563,112 | |||||||||||||
Gross margin |
75,221 | 54,987 | 226,705 | 199,746 | |||||||||||||
Research and development |
38,981 | 40,552 | 120,102 | 137,516 | |||||||||||||
Selling, general and administrative |
33,245 | 36,849 | 98,319 | 127,538 | |||||||||||||
Restructuring charges, net |
4,043 | | 6,096 | 47,221 | |||||||||||||
Total operating expenses |
76,269 | 77,401 | 224,517 | 312,275 | |||||||||||||
Operating income (loss) |
(1,048 | ) | (22,414 | ) | 2,188 | (112,529 | ) | ||||||||||
Other income (expense), net |
2,110 | 17,443 | (11,970 | ) | 17,762 | ||||||||||||
Income (loss) before income taxes |
1,062 | (4,971 | ) | (9,782 | ) | (94,767 | ) | ||||||||||
Income tax expense (benefit) |
265 | (6,540 | ) | 1,656 | (35,761 | ) | |||||||||||
Net income (loss) |
$ | 797 | $ | 1,569 | $ | (11,438 | ) | $ | (59,006 | ) | |||||||
Net income (loss) per share: |
|||||||||||||||||
Basic net income (loss) per share |
$ | 0.01 | $ | 0.01 | $ | (0.09 | ) | $ | (0.47 | ) | |||||||
Diluted net income (loss) per share |
$ | 0.01 | $ | 0.01 | $ | (0.09 | ) | $ | (0.47 | ) | |||||||
Number of shares used in
per share calculations: |
|||||||||||||||||
Basic |
125,988 | 126,747 | 126,110 | 125,921 | |||||||||||||
Diluted |
129,550 | 134,420 | 126,110 | 125,921 | |||||||||||||
See Notes to Condensed Consolidated Financial Statements.
4
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| Nine Months Ended | |||||||||
| March 30, | March 31, | ||||||||
| 2003 | 2002 | ||||||||
Cash flows from operating activities: |
|||||||||
Net loss |
$ | (11,438 | ) | $ | (59,006 | ) | |||
Adjustments to reconcile net loss to net cash
provided by (used for) operating activities: |
|||||||||
Loss (gain) on equity derivative contracts
in company stock |
16,407 | (17,718 | ) | ||||||
Depreciation and amortization |
30,504 | 46,332 | |||||||
Amortization of premiums on securities |
4,641 | 5,424 | |||||||
Deferred income taxes |
(5,426 | ) | (39,736 | ) | |||||
Restructuring charges, net |
5,795 | 54,821 | |||||||
Patent settlement |
| 33,780 | |||||||
Asset impairment charge |
| 11,500 | |||||||
Amortization of deferred compensation |
383 | | |||||||
Other |
354 | 1,730 | |||||||
Change in working capital accounts |
(3,676 | ) | (55,907 | ) | |||||
Net cash provided by/(used for) operating activities |
37,544 | (18,780 | ) | ||||||
Cash flows from investing activities: |
|||||||||
Capital expenditures |
(9,528 | ) | (8,518 | ) | |||||
Purchases of available-for-sale securities |
(360,339 | ) | (2,097,734 | ) | |||||
Sales and maturities of available-for-sale securities |
688,012 | 2,034,838 | |||||||
Purchase of investments for restricted cash, net |
(48,455 | ) | | ||||||
Other, net |
1,333 | (10,035 | ) | ||||||
Net cash provided by/(used for) investing activities |
271,023 | (81,449 | ) | ||||||
Cash flows from financing activities: |
|||||||||
Principal payments and redemptions on long-term
debt and capital lease obligations |
(361,259 | ) | (6,909 | ) | |||||
Treasury stock purchases |
(39,122 | ) | (10,678 | ) | |||||
Reissuances of treasury stock |
8,448 | 12,324 | |||||||
Proceeds from issuance of common stock |
6,160 | 14,270 | |||||||
Net cash provided by/(used for) financing activities |
(385,773 | ) | 9,007 | ||||||
Effect of exchange rate changes on cash |
1,181 | (352 | ) | ||||||
Net decrease in cash and
cash equivalents |
(76,025 | ) | (91,574 | ) | |||||
Cash and cash equivalents at beginning of period |
172,431 | 221,659 | |||||||
Cash and cash equivalents at end of period |
$ | 96,406 | $ | 130,085 | |||||
See Notes to Condensed Consolidated Financial Statements.
5
LAM RESEARCH CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 30, 2003
(Unaudited)
NOTE A BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of Lam Research Corporation (the Company or Lam) for the fiscal year ended June 30, 2002, which are included in the Annual Report on Form 10-K, File Number 0-12933. The Companys Form 10-K, Forms 10-Q and Forms 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is http://www.sec.gov. The Company also posts the Form 10-K, Forms 10-Q and Forms 8-K on the corporate website at http://www.lamrc.com.
The Companys reporting period is a 52/53-week fiscal year. The Companys current fiscal year will end June 29, 2003 and includes 52 weeks. The quarters ended March 30, 2003 and March 31, 2002 included 13 weeks.
Reclassifications: Certain amounts presented in the comparative financial statements for prior years have been reclassified to conform to the 2003 presentation.
NOTE B RECENT ACCOUNTING PRONOUNCEMENTS
Impairment or Disposals of Long-Lived Assets: In August 2001, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 144 (FAS 144) Accounting for the Impairment or Disposal of Long-Lived Assets. FAS 144 supersedes FAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, and applies to all long-lived assets (including discontinued operations). The Company adopted FAS 144 effective at the beginning of fiscal 2003. The adoption of FAS 144 did not have a material impact on the Companys consolidated financial position or operating results.
Costs associated with Exit or Disposal Activities: In July 2002, the FASB issued Statement of Financial Accounting Standards No. 146 Accounting for Costs Associated with Exit or Disposal Activities (FAS 146). FAS 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring) (EITF 94-3). The principal difference between FAS 146 and EITF 94-3 relates to FAS 146s requirements for the timing of recognizing a liability for a cost associated with an exit or disposal activity. FAS 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when
6
the liability is incurred. Under EITF 94-3 a liability for an exit cost was recognized at the date of an entitys commitment to an exit plan. FAS 146 is effective for exit or disposal activities that are initiated after December 31, 2002, with early adoption encouraged. The Company early-adopted FAS 146 in the quarter ended December 29, 2002 and applied its accounting provisions to the restructuring activities initiated during the quarters ended December 29, 2002 and March 30, 2003 (see Note N). No restructuring activities were initiated during the quarter ended September 29, 2002.
Accounting for Revenue Arrangements with Multiple Deliverables: In November 2002, the FASBs Emerging Issues Task Force reached a consensus on EITF Issue No. 00-21, Accounting for Revenue Arrangements with Multiple Deliverables (EITF 00-21). EITF 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple deliverables (products, services and/or rights to use assets). The provisions of EITF 00-21 will be applicable for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company is reviewing EITF 00-21 but has not yet determined the potential impact it will have on the Companys financial position or results of operations, if any.
Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others: In November 2002, the FASB issued Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (FIN 45). FIN 45 requires a company that is a guarantor to make specific disclosures about its obligations under certain guarantees that it has issued. FIN 45 also requires the guarantor to recognize, at the inception of a guarantee, a liability for the fair value of the obligations it has undertaken in issuing the guarantee. FIN 45 also incorporates, without change, the guidance in FASB Interpretation No. 34, Disclosure of Indirect Guarantees of Indebtedness of Others which is superseded by FIN 45. FIN 45s disclosure requirements are effective for financial statements for periods ending after December 15, 2002. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis to guarantees issued after December 31, 2002. The provisions of FIN 45 did not have a material impact on the Companys financial position or results of operations upon adoption. (See Note L).
Accounting for Stock-Based Compensation Transition and Disclosure: In December 2002, the FASB issued Statement of Financial Accounting Standards No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure (FAS 148), which amends Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation, (FAS 123). FAS 148 provides alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. In addition, FAS 148 amends the disclosure requirements of FAS 123 and requires prominent disclosure in both annual and interim financial statements of the method of accounting for stock-based employee compensation and the effect of the method used on a companys financial position and results of operations. The transition guidance and annual disclosure requirements of FAS 148 are effective for fiscal years ending after December 15, 2002. The Company adopted the interim disclosure requirements of FAS 148 for financial statements in its fiscal quarter ended March 30, 2003. The Company intends to continue to account for its stock option plans and stock purchase plan under the provisions of Accounting Principles Board Opinion No. 25 Accounting For Stock Issued to Employees (APB 25) and Interpretation No. 44, Accounting for Certain Transactions Involving Stock Compensation an Interpretation of APB Opinion No. 25 (FIN 44).
7
Accordingly, the adoption of FAS 148 is not anticipated to have a material impact on the Companys financial position or results of operations.
Consolidation of Variable Interest Entities: In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities (FIN 46), an interpretation of Accounting Research Bulletin No. 51, Consolidated Financial Statements. FIN 46 establishes accounting guidance for consolidation of a variable interest entity (VIE), sometimes formerly referred to as a special purpose entity. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. FIN 46 applies to any business enterprise, both public and private, that has a controlling interest, contractual relationship or other business relationship with a VIE. FIN 46 provides guidance for determining when an entity, the Primary Beneficiary, should consolidate another entity, a VIE, that functions to support the activities of the Primary Beneficiary. FIN 46 will require the consolidation of a VIE by a company if that company is subject to a majority of the risk of loss from the VIEs activities or entitled to receive a majority of the VIEs residual returns or both.
The effective date of the new rules under FIN 46 on the Companys existing operating leases is the first quarter of fiscal 2004, and immediately on any new leases entered into after January 31, 2003, which utilize VIEs or equivalent lease structures. The adoption of FIN 46 could potentially result in the Company having to consolidate the operating results of certain existing lessor entities which may be VIEs, as defined, and which are lessors under some of the Companys operating lease agreements and recognize the assets and related liabilities of the VIEs on the Companys balance sheet. However, FIN 46 is not anticipated to have a material impact on the Companys financial position or results of operations because the Company anticipates the operating lease agreements will be transferred to a new lessor that would not qualify as a VIE.
NOTE C STOCK-BASED COMPENSATION PLANS
The Company has adopted stock option plans that provide for the grant to key employees of options to purchase shares of Lam common stock. In addition, the plans permit the grant of nonstatutory stock options to paid consultants and employees, and provide for the automatic grant of nonstatutory stock options to outside directors. The Company also has a stock purchase plan that allows employees to purchase its common stock. The Company accounts for its stock option plans and stock purchase plan under the provisions of APB 25 and FIN 44.
For pro forma purposes, the estimated fair value of the Companys stock-based awards is amortized over the options vesting period (for options) and the respective four, six, twelve, or fifteen-month purchase periods (for stock purchases under the employee stock purchase plan). The following table illustrates the effect on net income (loss) and net income (loss) per share if the Company had accounted for its stock option and stock purchase plans under the fair value method of accounting under FAS 123, as amended by FAS 148:
8
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 30, | March 31, | March 30, | March 31, | |||||||||||||
| 2003 | 2002 | 2003 | 2002 | |||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||
Net income (loss) as reported |
$ | 797 | $ | 1,569 | $ | (11,438 | ) | $ | (59,006 | ) | ||||||
Add: compensation expense recorded under
APB 25, net of tax |
329 | | 458 | 1,718 | ||||||||||||
Deduct: FAS 123 compensation expense, net of tax |
10,297 | 8,031 | 33,537 | 24,579 | ||||||||||||
Net loss pro forma |
$ | (9,171 | ) | $ | (6,462 | ) | $ | (44,517 | ) | $ | (81,867 | ) | ||||
Basic net income (loss) per share as reported |
$ | 0.01 | $ | 0.01 | $ | (0.09 | ) | $ | (0.47 | ) | ||||||
Basic loss per share pro forma |
$ | (0.07 | ) | $ | (0.05 | ) | $ | (0.35 | ) | $ | (0.65 | ) | ||||
Diluted net income (loss) per share as reported |
$ | 0.01 | $ | 0.01 | $ | (0.09 | ) | $ | (0.47 | ) | ||||||
Diluted loss per share pro forma |
$ | (0.07 | ) | $ | (0.05 | ) | $ | (0.35 | ) | $ | (0.65 | ) | ||||